Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Phamacokinetics and safety profiles of DA-5210 10/500mg in Healthy subjects at Fed State
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sequence A | Experimental |
| |
| Sequence B | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DA-5210 10/500mg | Drug | single dose administration (one tablet once a day) |
|
| Measure | Description | Time Frame |
|---|---|---|
| AUCt | area under the curve | pre-dose~48 hours post-dose |
| Cmax | maximum plasma concentration | pre-dose~48 hours post-dose |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| H Plus Yangji Hospital | Seoul | 08779 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| DA-5210-R 10/500mg | Drug | single dose administration (one tablet once a day) |
|